Taking place June 21st – July 5th, 2026, in Shenzhen, BGI Group extends a warm welcome to your participation in the course of Applicable Smart Medical Technology Training Program for "Belt and Road" Countries. Organized by BGI College, this 15-day program is designed for mid- to senior-level prof...
Learn details
Choices, conviction and curiosity. These are the driving forces that have taken Wyclif Odago from the shores of Lake Victoria in Kenya to be a Project Operation Specialist at BGI Bioverse and a PhD candidate in Botany at the University of Chinese Academy of Sciences. As the fi...
Learn details
On March 17, a Dutch biotechnology delegation, organized by the Netherlands Innovation Network China and led by Antoni Mandemaker, Deputy Consul General of the Kingdom of the Netherlands in Guangzhou, visited the BGI Center, the global headquarters of BGI Group. The delegation engaged in high-lev...
Learn details
The world is grappling with a deepening food crisis, driven by the COVID-19 pandemic and the Ukraine war, as supply chains are severed and costs escalate. Climate shocks like drought and floods have also stoked global hunger, impacting food production, availability, and accessibility. Acco...
(Continued from PART 3) Question 3: Looking ahead, what is the direction of life science development? Dr. Xu Xun: We believe that in the next 20 years, genomics will still be a central part of life science. Genomics is a must for us to understand birth, aging, sickness and death and ultima...
(Continued from PART 2) Dr. Xu Xun: Single-cell sequencing has certain limitations as it requires tissue dissociation, and when cells dissociated, they lose spatial location information. As a result, when we see a group of specific type of cells, there is no way to explain what they do and...
(Continued from PART 1) Question 2: What progress and breakthroughs has life science research made today? Dr. Xu Xun: Single-cell sequencing and spatiotemporal omics technologies are two major research directions in today's global life sciences. Single-cell sequencing is a core br...
This year marks the 22nd anniversary of the assembly of the "working draft" of the human genome, and the 23rd anniversary of BGI's participation in the Human Genome Project (HGP) and our sequencing of 1% of the human genome. Innovations from that research continue t...
Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels, and the leading cause of death globally, representing about one-third of worldwide deaths. Nearly 18 million people died from CVDs in 2019, among which 85% were due to heart attack and stroke1. To manage high mortality...